An ophthalmic composition can include dexamethasone phosphate, or a salt thereof, dexamethasone, but in an amount not greater than 1.0 wt % relative to the amount of dexamethasone phosphate, or a salt thereof, and water. The ophthalmic composition can have a pH of about 5 to about 8 and a tonicity of from about 100 mOsm/kg to about 760 mOsm/kg.

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects.

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects.

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects.

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects.

A device for washing eyes is provided, comprising a container and a container locater.

Iontophoresis, a minimally-invasive methodology that uses a weak electric current to enhance penetration of ionized molecules into tissues, was found to be an effective technique for the intraocular delivery of large bioactive molecules, specifically lutein.

Devices and methods to apply eye drops are shown. Example devices include carrier strips with an amount of eye medication included on or within at least one end. In selected methods, a patient touches an end including an amount of medication to their eye, and an amount of the medication is transferred from the carrier to their eye.

Platform or system of drop-dispenser devices and method for use thereof, where one device in a platform is active in that it is equipped with a data-recording/transmitting/processing/feedback unit configured to provide feedback on whether a drop is delivered to the ROI as intended, while another device is passive in that (being otherwise substantially structurally similar in configuration and operation to the active device), it does not have such a unit and is structured to simply hold, stabilize, and/or or position a liquid-drop container to aid in successful delivery of the liquid drop(s). While using the system, the user may start using the passive device and switch to the use of an active device if the results of delivery of drops to the ROI with the passive device is unsatisfactory with respect to a schedule, or success rate, or for any other reason. The use may start using the active device first and, once the period of training (with the feedback provided by the active device) is over and the habit or routine of the use of the active device without supervision is satisfactoryswitch to the use of the passive device. The geometry of devices in the system is judiciously chosen to facilitate increase in success rate of as-intended drop delivery.

The present disclosure provides a portable drug dispenser which includes one or more chambers for holding a plurality of separately contained drug products, a dispensing mechanism for accurately dispensing one or more of the plurality of separately contained drugs upon activation of the dispensing mechanism in a specified dose (e.g. specified volume/number of drops) at specified times, and a processor configured to determine the time, and potentially other information such as, e.g. location, patient variables, user data input of each activation of the dispensing mechanism, and an ability to transmit the determined time of activation to a computer located remote to the dispenser, optionally stored on the device as well for read out by a clinician managing the patient.